Chronic Hepatitis C-Related Cirrhosis Hospitalization Cost Analysis in Bulgaria

Chronic Hepatitis C-Related Cirrhosis Hospitalization Cost Analysis in Bulgaria

ObjectiveHCV infection is a leading cause of chronic liver disease with long-term complications—extensive fibrosis, cirrhosis, and hepatocellular carcinoma. The objective of this study is to perform cost analysis of therapy of patients with chronic HCV-related cirrhosis hospitalized in the Universit...

Full description

Bibliographic Details
Main Authors:	Maria Dimitrova, Kaloyan Pavlov, Konstantin Mitov, Jordan Genov, Guenka Ivanova Petrova
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2017-08-01
Series:	Frontiers in Medicine
Subjects:	chronic HCV infection HCV-related cirrhosis hospitalizations cost analysis burden
Online Access:	http://journal.frontiersin.org/article/10.3389/fmed.2017.00125/full

Similar Items

RELATIVE FREQUENCY OF HEPATITIS B VIRUS AND HEPATITIS C VIRUS INFECTIONS IN PATIENTS OF LIVER CIRRHOSIS IN CHILDREN
by: Syed Nizam Hussain Shah, et al.
Published: (2020-02-01)

Molecular Mechanisms Driving Progression of Liver Cirrhosis towards Hepatocellular Carcinoma in Chronic Hepatitis B and C Infections: A Review
by: Tatsuo Kanda, et al.
Published: (2019-03-01)

CLINICAL AND BIOCHEMICAL CHARACTERISTICS AT THE CIRRHOSIS OF VARIOUS GENESIS
by: A. R. Bilalova, et al.
Published: (2016-06-01)

Consequences of inaccurate hepatitis C virus genotyping on the costs of prescription of direct antiviral agents in an Italian district
by: Polilli E, et al.
Published: (2016-09-01)

Cost per care of the first year of direct antiviral agents in the Liguria Region: a multicenter analysis
by: Cenderello G, et al.
Published: (2017-05-01)

Egy-score as a noninvasive score for the assessment of hepatic fibrosis in chronic hepatitis C: A preliminary approach
by: Mohamed Alboraie, et al.
Published: (2014-01-01)

Splenectomy in cirrhosis with hypersplenism: improvement in cytopenias, child's status and institution of specific treatment for hepatitis C with success
by: Saurabh Kedia, et al.
Published: (2012-11-01)

The peritoneal macrophage inflammatory profile in cirrhosis depends on the alcoholic or hepatitis C viral etiology and is related to ERK phosphorylation
by: Tapia-Abellán Ana, et al.
Published: (2012-08-01)

New therapies on the horizon for hepatitis C
by: Silvia C Sookoian, MD
Published: (2003-10-01)

Clinical and epidemiological features of chronic hepatitis C in the north-western region of Ukraine
by: T. I. Bevz
Published: (2020-02-01)

Factors Associated with Hepatitis C Infection among Chronic HCV Egyptian Patients.
by: Ekram W Abd El-Wahab, et al.
Published: (2014-11-01)

Vitamin D deficiency is a risk factor for infections in patients affected by HCV-related liver cirrhosis
by: Antonio Riccardo Buonomo, et al.
Published: (2017-10-01)

Safety, Tolerability, and Preliminary Efficacy of the Anti-Fibrotic Small Molecule PRI-724, a CBP/β-Catenin Inhibitor, in Patients with Hepatitis C Virus-related Cirrhosis: A Single-Center, Open-Label, Dose Escalation Phase 1 Trial
by: Kiminori Kimura, et al.
Published: (2017-09-01)

Clinical Findings of HCV Chronic Infection in Undocumented Immigrants and Low-Income Refugees in Three Areas of Southern Italy
by: Evangelista Sagnelli, et al.
Published: (2018-01-01)

Hepatitis C virus quantification in serum and saliva of HCV-infected patients
by: Gisele Barreto Lopes Menezes, et al.
Published: (2012-08-01)

Effect of sustained virologic response on the incidence of hepatocellular carcinoma in patients with HCV cirrhosis
by: Nelson Cheinquer, et al.

Trends in the Acute Hepatitis B and Acute Hepatitis C in Bulgaria
by: Baymakova Magdalena P., et al.
Published: (2019-06-01)

Long non-coding RNA HOTAIR and HOTTIP as potential biomarkers for hepatitis C virus genotype 4-induced hepatocellular carcinoma
by: Fawzy Roshdy, et al.
Published: (2020-02-01)

Universal Index for Cirrhosis (UIC index): The development and validation of a novel index to predict advanced liver disease
by: Ahmed Z, et al.
Published: (2018-10-01)

Investigation of Genotype Distribution in Hepatitis C Patients in Giresun Province
by: Serpil GENÇ, et al.
Published: (2020-12-01)

Treatment of Chronic HCV Infection in Special Populations
Published: (2006-04-01)

Budget impact analysis of sofosbuvir-based regimens for the treatment of HIV/HCV-coinfected patients in northern Italy: a multicenter regional simulation
by: Cenderello G, et al.
Published: (2015-12-01)

Hepatitis C virus infection in patients and family members attending two primary care clinics in Puebla, Mexico
by: Aurelio López-Colombo, et al.
Published: (2014-11-01)

Clinical case of difficult differential diagnosis between liver cirrhosis and hepatocellular carcinoma associated with HCV infection in a patient with prolonged alcohol exposure
by: Baramzina S.V.
Published: (2019-12-01)

The epidemiologic burden of hepatitis C virus infection in Latin America
by: Shelagh M. Szabo, et al.
Published: (2012-09-01)

NON-INVASIVE TOOLS TO ASSESS THE RISK OF VARICES-NEEDING-TREATMENT IN CIRRHOSIS SECONDARY TO HCV
by: Laima Alam, et al.
Published: (2021-02-01)

Interleukin-18 polymorphism as a diagnostic tumor marker for hepatocellular carcinoma in patients with hepatitis C-related cirrhosis
by: Ayman Abdelghaffar Eldesoky, et al.
Published: (2020-11-01)

Prediction of esophageal varices in patients with HCV-related cirrhosis using albumin-bilirubin, platelets-albumin-bilirubin score, albumin-bilirubin-platelets grade, and GAR
by: Ayman Alsebaey, et al.
Published: (2020-05-01)

Annexin A5 as a marker for hepatocellular carcinoma in cirrhotic hepatitis C virus patients
by: Waleed Mohamed Serag, et al.
Published: (2021-05-01)

Styl życia chorych z marskością wątroby zakażonych wirusem HCV = Life style of patients with cirrhosis infected with HCV virus
by: Lidia Sierpińska, et al.
Published: (2016-10-01)

Detection and distribution of genotypes of Hepatitis C in a tertiary care hospital
by: Upasana Bhumbla, et al.
Published: (2020-01-01)

Prevalence and Genotypic Distribution of Hepatitis C Virus in Peshawar KPK, Pakistan
by: Tanweer Kumar, et al.
Published: (2017-01-01)

Specific damage to the kidneys in patients with chronic hepatitis C associated with cryoglobulinemia
by: Svetlana Yur'evna Milovanova, et al.
Published: (2011-11-01)

The distribution of hepatitis C virus genotypes in patients with hepatocellular carcinoma
by: Ayfer Bakır, et al.
Published: (2019-10-01)

Change in hepatitis C virus positivity among needle-stick injury source patients: a 10-year experience in a Japanese tertiary hospital
by: Kazuya Okushin, et al.
Published: (2021-04-01)

Cost-effectiveness analysis with direct-acting antivirals in a cohort of HCV-infected inmates in Italy
by: Roberto Ravasio, et al.
Published: (2020-12-01)

Sustained virological response after ten days of triple anti-hepatitis C virus (HCV) therapy with telaprevir plus pegylated interferon and ribavirin in an HIV/HCV co-infected cirrhotic woman
by: Hamid Hasson, et al.
Published: (2014-12-01)

Directly Acting Antiviral-Based Treatment for HCV-Infected Persons Who Inject Drugs: A Multicenter Real-Life Study
by: Vincenzo Messina, et al.
Published: (2021-12-01)

Case-term Adverse Outcomes of Chronic Hepatitis C, Extrahepatic Manifestations of a Young Man Infected in Early Childhood
by: S. V. Baramzina, et al.
Published: (2015-12-01)

Mortality rates and risk factors in 1412 Japanese patients with decompensated hepatitis C virus-related cirrhosis: a retrospective long-term cohort study
by: Shunichiro Fujiyama, et al.
Published: (2021-04-01)